Literature DB >> 9007690

A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists.

L Belvisi1, G Bravi, G Catalano, M Mabilia, A Salimbeni, C Scolastico.   

Abstract

A series of non-peptide angiotensin II receptor antagonists was investigated with the aim of developing a 3D QSAR model using comparative molecular field analysis descriptors and approaches. The main goals of the study were dictated by an interest in methodologies and an understanding of the binding requirements to the AT1 receptor. Consistency with the previously derived activity models was always checked to contemporarily test the validity of the various hypotheses. The specific conformations chosen for the study, the procedures invoked to superimpose all structures, the conditions employed to generate steric and electrostatic field values and the various PCA/PLS runs are discussed in detail. The effect of experimental design techniques to select objects (molecules) and variables (descriptors) with respect to the predictive power of the QSAR models derived was especially analysed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007690     DOI: 10.1007/bf00134180

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  12 in total

1.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

Review 2.  Peptides and central neural regulation of the circulation.

Authors:  J L Reid; P C Rubin
Journal:  Physiol Rev       Date:  1987-07       Impact factor: 37.312

3.  Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.

Authors:  P R Bovy; D B Reitz; J T Collins; T S Chamberlain; G M Olins; V M Corpus; E G McMahon; M A Palomo; J P Koepke; G J Smits
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

4.  A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists.

Authors:  L Belvisi; G Bravi; C Scolastico; A Vulpetti; A Salimbeni; R Todeschini
Journal:  J Comput Aided Mol Des       Date:  1994-04       Impact factor: 3.686

5.  Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles.

Authors:  A Salimbeni; R Canevotti; F Paleari; F Bonaccorsi; A R Renzetti; L Belvisi; G Bravi; C Scolastico
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

6.  New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives.

Authors:  R H Bradbury; C P Allott; M Dennis; J A Girdwood; P W Kenny; J S Major; A A Oldham; A H Ratcliffe; J E Rivett; D A Roberts
Journal:  J Med Chem       Date:  1993-04-30       Impact factor: 7.446

7.  New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.

Authors:  A P Thomas; C P Allott; K H Gibson; J S Major; B B Masek; A A Oldham; A H Ratcliffe; D A Roberts; S T Russell; D A Thomason
Journal:  J Med Chem       Date:  1992-03-06       Impact factor: 7.446

8.  Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.

Authors:  P R Bovy; J T Collins; G M Olins; E G McMahon; W C Hutton
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

9.  Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.

Authors:  D J Carini; J V Duncia; P E Aldrich; A T Chiu; A L Johnson; M E Pierce; W A Price; J B Santella; G J Wells; R R Wexler
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

10.  New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.

Authors:  R H Bradbury; C P Allott; M Dennis; E Fisher; J S Major; B B Masek; A A Oldham; R J Pearce; N Rankine; J M Revill
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

View more
  2 in total

1.  Effect of steric molecular field settings on CoMFA predictivity.

Authors:  Ruchi R Mittal; Ross A McKinnon; Michael J Sorich
Journal:  J Mol Model       Date:  2007-11-24       Impact factor: 1.810

2.  www.3d-qsar.com: a web portal that brings 3-D QSAR to all electronic devices-the Py-CoMFA web application as tool to build models from pre-aligned datasets.

Authors:  Rino Ragno
Journal:  J Comput Aided Mol Des       Date:  2019-10-08       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.